FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to phthisiology, and allows to carry out correction of dsychvegetative dysfunctions and prophylaxis of neuro- and cardiotoxic responses to polychemical therapy in patients with tuberculosis. Method includes introduction of afobazole in dose 10 mg three times a day daily during 30 days at the background of tuberculosis chemical therapy.
EFFECT: including afobazole into complex therapy of patients with tuberculosis allows to optimise results of tuberculosis treatment due to normalisation of vegetative nervous system function, reduction of psychic disorder expression, improvement of tolerance to anti-tuberculosis medications by patients.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| WAY OF PREVENTION OF COLLATERAL NEURO - CARDIO - AND HEPATOTOXIC REACTIONS TO ANTITUBERCULOUS PREPARATIONS | 2007 |
|
RU2362558C1 |
| METHOD OF INCREASING ADHERENCE TO ANTI-TUBERCULOSIS THERAPY | 2023 |
|
RU2808910C1 |
| METHOD FOR PREVENTION OF COMPLICATIONS INDUCED BY ISONIAZID | 2015 |
|
RU2597788C1 |
| METHOD OF INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS WITH TUBERCULOSIS | 2015 |
|
RU2611398C1 |
| METHOD FOR PREDICTING THERAPEUTIC EFFICACY OF APHOBAZOLUM ANXIOLYTIC IN PATIENTS WITH ANXIETY DISORDERS | 2019 |
|
RU2736391C1 |
| Pleurotus 1137 PREPARATION FOR DRUG HYPERSENSITIVITY CORRECTION IN INTEGRATED THERAPY OF PULMONARY TUBERCULOSIS | 2010 |
|
RU2435600C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF ARRHYTHMIAS IN ADOLESCENTS WITH RESPIRATORY TUBERCULOSIS | 2023 |
|
RU2814004C1 |
| AUTOLOGOUS COMPOSITION AND METHOD FOR TREATING PULMONARY TUBERCULOSIS WITH DRUG RESISTANCE OF THE PATHOGEN AND ABSENCE OF EFFECT AGAINST THE BACKGROUND OF POLYCHEMOTHERAPY | 2020 |
|
RU2771843C2 |
| METHOD FOR PREDICTION OF RISK OF MYCOBACTERIUM TUBERCULOSIS RESISTANCE TO FLUOROQUINOLONES IN TUBERCULOSIS PATIENTS WITH MULTIPLE RESISTANCE | 2014 |
|
RU2558992C1 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2003 |
|
RU2243776C1 |
